3,3’-Diindolylmethane Enhances Paclitaxel Sensitivity by Suppressing DNMT1-Mediated KLF4 Methylation in Breast Cancer

Paclitaxel (PTX) is a first-line chemotherapeutic drug for the treatment of breast cancer, but drug resistance seriously limits its clinical use. The aim of the present work was to explore the effect of 3,3’-diindolylmethane (DIM) on PTX sensitivity and its possible mechanism in breast cancer. The e...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Fenfen, Zhu, Zhaowei, Zhang, Mengzhe, Wang, Jie, Chen, Zixi, Li, Xiaoxiao, Zhang, Tao, Gu, Qing, Wu, Rong, Kang, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209418/
https://www.ncbi.nlm.nih.gov/pubmed/34150611
http://dx.doi.org/10.3389/fonc.2021.627856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209418/
https://www.ncbi.nlm.nih.gov/pubmed/34150611
http://dx.doi.org/10.3389/fonc.2021.627856

Ejemplares similares